Subclinical arterial and cardiac damage in white-coat and masked hypertension

Blood Pressure

Volumn 25, Issue 4, 2016, Pages 249-256

  Wojciechowska, Wiktoria ^a   Stolarz Skrzypek, Katarzyna ^a   Olszanecka, Agnieszka ^a   Klima, Łukasz ^a   Gąsowski, Jerzy ^a   Grodzicki, Tomasz ^a   Kawecka Jaszcz, Kalina ^a   Czarnecka, Danuta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Ambulatory blood pressure monitoring; arterial stiffness; left ventricle diastolic dysfunction; left ventricular hypertrophy; masked hypertension; white coat hypertension

Indexed keywords

CHOLESTEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITOR; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART INJURY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MIDDLE AGED; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; ULTRASOUND SCANNER; WHITE COAT HYPERTENSION; ARTERIAL STIFFNESS; BLOOD PRESSURE; CAROTID ARTERY; DIAGNOSTIC IMAGING; HEART; PATHOPHYSIOLOGY;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; MASKED HYPERTENSION; MIDDLE AGED; ULTRASONOGRAPHY; VASCULAR STIFFNESS; WHITE COAT HYPERTENSION;

EID: 84961201523     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2016.1150563     Document Type: Article

References (22)

1. G.Parati, G.Stergiou, E.O’Brien, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359–1366.
2. T.W.Hansen, M.Kikuya, L.Thijs, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25:1554–1564.
3. G.S.Stergiou, K.Asayama, L.Thijs, et al. Prognosis of white-coat and masked hypertension: international database of home blood pressure in relation to cardiovascular outcome. Hypertension. 2014;63:675–682.
4. G.Mancia, R.Fagard, K.Narkiewicz, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. Blood Press. 2013;22:193–278.
5. V.Kotsis, S.Stabouli, S.Toumanidis, et al. Target organ damage in “white coat hypertension” and “masked hypertension”. Am J Hypertens. 2008;21:393–399.
6. M.Fukuhara, H.Arima, T.Ninomiya,. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study. Stroke. 2013;44:1512–1517.
7. M.R.Hänninen, T.J.Niiranen, P.J.Puukka, et al. Target organ damage and masked hypertension in the general population: the Finn-Home study. J Hypertens. 2013;31:1136–1143.
8. K.Asayama, L.Thijs, Y.Li, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension. 2014;64:935–942.
9. J.M.A.D.Bland Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;8:307–310.
10. W.Wojciechowska, J.A.Staessen, T.Nawrot, et al. Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res. 2006;29:475–483.
11. J.S.Gottdiener, J.Bednarz, R.Devereux, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17:1086–1119.
12. N.B.Schiller, P.M.Shah, M.Crawford, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367.
13. C.Cuspidi, C.Sala, M.Tadic, et al. Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Blood Press Monit. 2015;20:57–63.
14. C.Cuspidi, C.Sala, M.Tadic, et al. Untreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysis. Am J Hypertens. 2015;28:806–813.
15. Y.Karter, A.Curgunlu, S.Altinişik, et al. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Press. 2003;12:307–313.
16. T.Nakashima, S.Yamano, R.Sasaki,. White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens Res. 2004;27:739–745.
17. S.D.Pierdomenico, D.Lapenna, R.Di Mascio, et al. Short- and long-term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens. 2008;22:408–414.
18. C.Cuspidi, M.Rescaldani, M.Tadic, et al. White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J Hypertens. 2015;33:24–32.
19. P.H.Gustavsen, A.Høegholm, L.E.Bang, et al. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens. 2003;17:811–817.
20. S.H.Sung, H.M.Cheng, K.L.Wang, et al. White coat hypertension is more risky than prehypertension: Important role of arterial wave reflections. Hypertension. 2013;61:1346–1353.
21. S.S.Franklin, L.Thijs, Y.Li, et al. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension. 2013;61:964–971.
22. S.Lewington, R.Clarke, N.Qizilbash, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.